SETD2 and nonpapillary renal cell carcinoma: Indeed, mutations in SETD2 occur in ~ 25% of primary ccRCC but increase to > 60% in ccRCC metastases [4, 5, 6], suggesting SETD2 plays an important role in the transition from primary to metastatic ccRCC.